Revenue dropped sharply in H1 2025 due to a US distributor change, with losses deepening from higher PMTA costs, inventory write-downs, and currency effects. New financing and a fresh US commercial strategy aim to restore growth from September.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.